The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...
Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...
India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven ...
Republic Business on MSN3h
'India's pharma exports expected to remain strong amid global slowdown'Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...
After third-party manufacturing issues led to a December rejection of Zealand Pharma’s pediatric congenital hyperinsulinism (CHI) candidate, the Danish pharma’s latest snub seems to come down to ti | ...
Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...
This campaign invites people to engage with oversized, emotion-infused blooms, reminding them that sometimes the simplest ...
The business stated that the authorised ANDA is therapeutically similar to the reference-listed drug product (RLD) Lastacaft ...
1h
Sharad Avasthi, from SMIFS, shares an in-depth analysis of the entire pharma sector, highlighting improved margins driven by ...
The maker of pharmaceutical inputs and bulk drugs said there was no Form 483 observation after the USFDA inspection of its ...
Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...
Korea Joongang Daily on MSN4h
Korean pharma seeks closer ties with Japan at Asia's largest biotech showKorean biopharmaceutical companies are exploring opportunities at Bio Japan 2024 amid U.S.-China tensions, with major firms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback